Results 121 to 130 of about 3,533 (177)

Redesign of Schistosoma mansoni NAD+ catabolizing enzyme: active site H103W mutation restores ADP-ribosyl cyclase activity. [PDF]

Biochemistry, 2006
Kuhn I, Kellenberger E, Rognan D, Lund FE, Muller-Steffner H, Schuber F.   +5 more
europepmc   +1 more source

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti-CD38 therapies in multiple myeloma. [PDF]

Blood Cancer J
Giorgetti G, Maroto-Martin E, Soncini D, Fenoglio D, Becherini P, Benzi A, Ravera S, Traverso I, Ladisa F, Lai F, Rivoli G, Truffelli D, Nahimana A, Cagnetta A, Guolo F, Uras CRM, Schavgoulidze A, Fong Ng J, Nencioni A, Bruzzone S, Munshi NC, Lemoli RM, Fulciniti M, Cea M.   +23 more
europepmc   +1 more source

Acute Rejection With DSA-Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04-Mismatch Successfully Stabilised With Daratumumab. [PDF]

HLA
Knödl L, Büttner-Herold M, Götz M, Luber M, Spriewald B, Oellerich M, Beck J, Banas B, Zecher D.   +8 more
europepmc   +1 more source

CD38-dependent ADP-ribosyl cyclase activity in developing and adult mouse brain. [PDF]

Biochem J, 2003
Ceni C, Pochon N, Brun V, Muller-Steffner H, Andrieux A, Grunwald D, Schuber F, De Waard M, Lund F, Villaz M, Moutin MJ.   +10 more
europepmc   +1 more source

Predicting Positive Affect in Infancy. [PDF]

Dev Sci
Grossmann T, Miller H, Allison O.
europepmc   +1 more source

Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases. [PDF]

Protein Sci
Kim HS, Hariri K, Zhang XN, Chen LC, Katz BB, Pei H, Louie SG, Zhang Y.   +7 more
europepmc   +1 more source

Editorial: Adenine nucleotides in immunity and inflammation. [PDF]

Front Immunol
Müller CE, Bruzzone S, Guse AH.
europepmc   +1 more source

Diazirine-AIOC-NAADP, a Clickable-Photoactive NAADP Analog for Sea Urchin NAADP Binding Proteins. [PDF]

ACS Chem Biol
Zhang Y, Guan Z, Gadient JN, Kumar S, Gunaratne G, Walseth TF, Marchant JS, Wall KA, Slama JT.   +8 more
europepmc   +1 more source

Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy. [PDF]

Oncoimmunology
Vijayan VV, Nair PG, Gujar S.
europepmc   +1 more source

Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.

Am J Physiol Renal Physiol, 2009
Thai TL, Arendshorst WJ.
europepmc   +1 more source